High dose intravenous immunoglobulin does not improve abnormalities in the blood-brain barrier during acute relapse of multiple sclerosis

J Neurol Neurosurg Psychiatry. 1996 Oct;61(4):418. doi: 10.1136/jnnp.61.4.418-a.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Inflammatory Agents / pharmacology*
  • Anti-Inflammatory Agents / therapeutic use*
  • Blood-Brain Barrier / drug effects*
  • Dose-Response Relationship, Drug*
  • Humans
  • Methylprednisolone / administration & dosage*
  • Methylprednisolone / pharmacology*
  • Methylprednisolone / therapeutic use*
  • Multiple Sclerosis / drug therapy*
  • Recurrence

Substances

  • Anti-Inflammatory Agents
  • Methylprednisolone